Wanqiang Sheng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Dna Methylation

Mesenchymal Stem Cells

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature communications 15 (1) (2024)
Yi Liu, Brian Debo, Mingfeng Li, Zhennan Shi, Wanqiang Sheng, Yang Shi
Author Correction: LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. Nature communications 13 (1) (2022)
Yi Liu, Brian Debo, Mingfeng Li, Zhennan Shi, Wanqiang Sheng, Yang Shi
LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. Nature communications 12 (1) (2021)